Scott E. Kasner

发表

Transcranial Laser Therapy in Acute Stroke Treatment: Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial

Majaz Moonis, Christian Weimar, Carlos Molina, 2014, Stroke.

Stroke: Pathophysiology, Diagnosis, and Management

Joseph P. Broderick, Ralph L. Sacco, Eng H. Lo, 2015 .

Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey

Andrew M. Demchuk, D. Tanné, A. Demchuk, 2002, Circulation.

MRI identification of early white matter injury in anoxic–ischemic encephalopathy

Joseph A. Maldjian, Ronald L. Wolf, Scott E. Kasner, 2001 .

Aphemia: an isolated disorder of articulation

Robert J. Fox, Anjan Chatterjee, A. Chatterjee, 2001, Clinical Neurology and Neurosurgery.

Optical Bedside Monitoring of Cerebral Blood Flow in Acute Ischemic Stroke Patients During Head-of-Bed Manipulation

John A. Detre, Arjun G. Yodh, Turgut Durduran, 2014, Stroke.

Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis

Harry J. Cloft, David S. Liebeskind, Louis R. Caplan, 2003, Neuroepidemiology.

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke

Helle K. Iversen, John F. Rhodes, David J. Spence, 2017, The New England journal of medicine.

Neuroprotection for Ischaemic Stroke

David S. Liebeskind, S. Kasner, D. Liebeskind, 2001, CNS drugs.

An Updated Definition of Stroke for the 21 st Century

Joseph P. Broderick, Jin-Moo Lee, Mary G. George, 2013 .